- Home
- ZION vs LNTH Comparison
ZION vs LNTH Comparison
Compare ZION & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZION
- LNTH
- Stock Information
- Founded
- ZION 1873
- LNTH 1956
- Country
- ZION United States
- LNTH United States
- Employees
- ZION N/A
- LNTH N/A
- Industry
- ZION Major Banks
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ZION Finance
- LNTH Health Care
- Exchange
- ZION Nasdaq
- LNTH Nasdaq
- Market Cap
- ZION 7.4B
- LNTH 7.5B
- IPO Year
- ZION N/A
- LNTH 2015
- Fundamental
- Price
- ZION $49.47
- LNTH $96.16
- Analyst Decision
- ZION Hold
- LNTH Strong Buy
- Analyst Count
- ZION 22
- LNTH 6
- Target Price
- ZION $59.24
- LNTH $129.83
- AVG Volume (30 Days)
- ZION 2.3M
- LNTH 876.3K
- Earning Date
- ZION 04-21-2025
- LNTH 05-01-2025
- Dividend Yield
- ZION 3.48%
- LNTH N/A
- EPS Growth
- ZION 13.92
- LNTH N/A
- EPS
- ZION 4.95
- LNTH 4.36
- Revenue
- ZION $3,058,000,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- ZION $9.91
- LNTH $6.59
- Revenue Next Year
- ZION $5.06
- LNTH $11.80
- P/E Ratio
- ZION $9.99
- LNTH $22.06
- Revenue Growth
- ZION 2.51
- LNTH 18.32
- 52 Week Low
- ZION $39.05
- LNTH $58.16
- 52 Week High
- ZION $63.22
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ZION 42.02
- LNTH 48.12
- Support Level
- ZION $48.53
- LNTH $94.80
- Resistance Level
- ZION $51.99
- LNTH $100.73
- Average True Range (ATR)
- ZION 1.38
- LNTH 3.97
- MACD
- ZION 0.39
- LNTH -0.97
- Stochastic Oscillator
- ZION 56.55
- LNTH 8.41
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.